Stunning amber fossil reveals ‘Last of Us'-type fungus likely lived alongside dinosaurs
The insect, along with a second specimen of a young ant infected with a similar fungus, are two of the oldest examples of a bizarre natural phenomenon that involves fungal parasites hijacking the bodies of their hosts before ultimately killing them.
'Amber gives us this opportunity to visualize the ancient ecological relationships preserved in fossils,' said Yuhui Zhuang, a doctoral student at the Institute of Paleontology at Yunnan University in southwestern China.
'Overall, these two fossils are very rare, at least among the tens of thousands of amber specimens we've seen, and only a few have preserved the symbiotic relationship between fungi and insects,' added Zhuang, the lead author of a study on the fossils published June 11 in the journal Proceedings of the Royal Society B: Biological Sciences.
Zhuang and his colleagues named two previously unknown species of ancient fungi of the genus Ophiocordyceps from their research on the amber, which involved using optical microscopes to study the tiny pieces of amber and micro-computed tomography to make 3D images of the fungi-infected insects. They found the first, named Paleoophiocordyceps gerontoformicae, on the ant and the second, Paleoophiocordyceps ironomyiae, on the fly.
Some Ophiocordyceps species that prey on ant species today are known as 'zombie-ant fungi' because the fungal parasite can manipulate the behavior of its hosts for its own benefit. The phenomenon inspired the video game behind the HBO TV show 'The Last of Us.' HBO shares a parent company, Warner Bros. Discovery, with CNN.
'The discovery of these two fossils suggests that terrestrial ecosystems were already very complex, and that Ophiocordyceps, in particular, may have begun to act as 'predators' of insects in the Cretaceous period, regulating the populations of certain groups,' Zhuang said via email.
Today, parasitic fungi, also known as entomopathogenic fungi, infect a wide range of insect groups, including ants, flies, spiders, cicadas and beetles, according to London's Natural History Museum.
In the case of carpenter ants, the spore of the Ophiocordyceps fungus lands on the head of an ant, enters its brain through a weak area in the insect's exoskeleton and takes control of the ant to facilitate its spread, said Conrad Labandeira, senior scientist and curator of fossil arthropods at the Smithsonian Museum of Natural History in Washington, DC, who wasn't involved in the study.
Paleoophiocordyceps likely zombified its hosts in similar ways, according to Labandeira.
'It appears that ants, for some reason, were targeted early for zombification, and currently are the major recipients of this parasitoid fungus,' Labandeira said. He added that flies are only rarely affected by these parasitic fungi today, making a fossilized example particularly interesting.
The species of fungus that infected the prehistoric ant may be an ancestor of zombie-ant fungi, and thus likely controlled its host's body in similar ways, said study coauthor João Araújo, mycology curator and assistant professor at the Danish Natural History Museum. Very few specimens of ancient parasitic fungi have been discovered, so little is known about their evolution.
The two insects were likely killed by the fungi before getting trapped in the sticky tree resin that ultimately forms amber, said Araújo, noting that most entomopathogenic fungi kill their hosts to produce the fruiting body.
This lost parasite diversity had a significant role in shaping the planet we live on today, said Phil Barden, an associate professor at New Jersey Institute of Technology's department of biological sciences, who has worked on amber fossils.
'Even as we find a remarkable diversity of organisms entombed in amber, it's important to remember that we really do only capture the smallest glimpse. For any given fossil ant or beetle, we can imagine all of the parasites, fungus, and bacteria that such insects support,' Barden, who wasn't involved in the new study, said via email.
It was 'fascinating to see some of the strangeness of the natural world that we see today was also present at the height of the age of the dinosaurs,' said study coauthor Edmund Jarzembowski, a professor and associate scientist at London's Natural History Museum.
The fossil is the latest to emerge from Myanmar's rich amber fields.
While amber fossils have been some of paleontology's most exciting finds in recent years, ethical concerns about the provenance of amber from the civil war-torn region have emerged.
Zhuang said the fossils were sourced from Myanmar's amber markets. The study noted that the specimens were acquired before 2017 and, to the authors' knowledge, were not involved in armed conflict or ethnic strife.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
7 hours ago
- CNET
Ultrahuman Calls Ring Air the World's Most Accurate Ovulation-Tracking Smart Ring After New Acquisition
Ultrahuman has taken an algorithm designed for intravaginal fertility monitors and transformed it into a non-invasive, temperature-sensing feature that can track your cycle right from your finger. The wearable health tech company announced today that it acquired viO HealthTech, which created the OvuSense algorithm. Validated in 13 peer-reviewed clinical publications and backed by 15 years of clinical research, the algorithm draws on data from over 260,000 cycles collected with medical-grade sensors. It was previously used in class II intravaginal medical fertility monitors. Now, Ultrahuman has adapted that technology for wellness tracking to create its Cycle and Ovulation Pro PowerPlug for the Ring Air. In a press release, Ultrahuman said Cycle and Ovulation Pro delivers over 90% accuracy in confirming ovulation -- a level the company says makes the Air the "world's most accurate cycle-tracking smart ring." This data comes from equivalence testing that compared OvuSense and Ring AIR with a multi-hormone ovulation prediction method that tracks rises in luteinizing hormone and progesterone. Though other cycle trackers may report different ovulation confirmation rates -- for example, the Oura Ring claims 96.4% -- that data isn't directly comparable to OvuSense and Ring Air's testing due to differences in validation protocols, datasets and definitions of detection. Ultrahuman Most platforms that track menstrual cycles rely on a 28-day cycle, but Cycle and Ovulation Pro takes into consideration that 87% of people who menstruate have varying cycles due to conditions such as polycystic ovary syndrome, endometriosis, non-bleeding, thyroid disorders or irregular bleeding. "This collaboration benefits from 15 years of clinically proven women's health expertise and applies it to the world's lightest smart ring," said Mohit Kumar, Ultrahuman CEO, in the press release. "For the first time, best-in-class hardware, software and algorithms with a clinical background come together in one wellness device. Our mission is to give women cutting-edge tools to optimize their health, combining clinical technology with comfort and style to deliver the most accurate women's health tool available." Cycle and Ovulation Pro complements Ultrahuman Ring Air's existing free Cycle and Ovulation PowerPlug, which provides basic conception and cycle tracking. Using physiological patterns and temperature biomarkers passively captured by the smart ring, the Pro version can support fertility planning, offer a space for mood, symptom and behavior logging and use temperature data to suggest hidden patterns in a cycle. Known as Cycle Flags, these patterns may include early, late or absent ovulation, a short luteal phase and trends potentially linked to conditions such as PCOS or miscarriage risk. Ultrahuman While the OvuSense algorithm is FDA-cleared for intravaginal use, the adapted, non-invasive version for the Ultrahuman Ring Air was created for general wellness and isn't FDA-cleared. In other words, the Ring Air isn't a substitute for contraception or for professional medical diagnosis and treatment. For those, you should consult your health care provider. How much does Ultrahuman's Cycle and Ovulation Pro cost? Now available in the US, UK, EU, Australia and Canada, Cycle and Ovulation Pro is a premium PowerPlug in the Ultrahuman app that costs $3.99 per month or $39.99 per year. The current Cycle and Ovulation PowerPlug remains free.
Yahoo
12 hours ago
- Yahoo
Understanding tick immunity may be key to preventing killer viruses from spreading
A tiny tick crawls across your skin, potentially carrying a virus so lethal it kills up to four out of every ten people it infects. Yet that same tick shows no signs of illness whatsoever – it feeds, moves and reproduces as if nothing is wrong. Scientists studying severe fever with thrombocytopenia syndrome virus (SFTSV) have long wondered why this happens. The pathogen, first identified in China in 2009, causes high fevers, bleeding and organ failure in humans, but leaves ticks completely unharmed. Alongside colleagues, I conducted research into how ticks can carry deadly viruses without becoming ill themselves. Understanding these resistance mechanisms could help scientists develop new ways to block or weaken tick-borne diseases before they spill over into humans or animals. The findings come as climate change pushes ticks into new territories around the world. The Asian longhorned tick that carries SFTSV has been identified in Australia, New Zealand and the eastern US, raising concerns the disease could spread to regions that have never seen it before. Unlike mice, humans or even mosquitoes, ticks pose a unique scientific challenge: most of the molecular tools researchers use to study infection simply don't work in ticks. Instead, we turned to data analysis. We captured detailed molecular snapshots of infected tick cells, tracking thousands of genes and more than 17,000 proteins simultaneously. This allowed the team to study the cellular response comprehensively, at different time post-infection. We found that while human cells respond to viral invasion by mounting aggressive immune responses, mobilising multiple defence systems to fight the infection, tick cells take a fundamentally different approach. Survival strategy Ticks do have immune systems but they operate very differently from ours. Like humans, ticks have cellular signalling pathways that help detect and respond to infection. Known as Toll, IMD and JAK-STAT, these pathways coordinate defensive responses and trigger the production of antimicrobial proteins. But when infected with SFTSV, the tick's immune system showed only minimal activity. Instead of launching full-scale defensive responses, these pathways remained largely quiet. The virus appears to have evolved ways to avoid triggering the tick's immune alarm bells. Instead, the tick cells made major changes to their stress response systems, their production of RNA and proteins, and the pathways that control cell death. (RNA is a molecule that carries genetic instructions – like a working copy of DNA – used by cells to make proteins.) Rather than attacking the virus head-on, tick cells seem to tolerate the infection, reorganising their internal machinery to manage the damage while continuing to function. This approach makes evolutionary sense when you consider the constraints these tiny creatures face. Mounting a full-blown immune response is energetically expensive – it requires lots of resources and can harm the host's own tissues. For ticks, which feed only a few times in their life and live off limited energy reserves, a gentler response may be more sustainable. And because this virus has likely been infecting ticks for millions of years, the two have had time to adapt to each other. Rather than killing the host, the virus may have evolved to fly under the radar, while the tick evolved ways to tolerate it – allowing both to survive and reproduce. Unexpected antiviral guardians We identified two key proteins that act as molecular RNA quality controllers. These proteins, called UPF1 and DHX9, are ancient guardians found in all complex life forms, from plants to humans. One of their normal functions involves monitoring and controlling the quality of RNA, the molecular messenger that carries genetic instructions around cells. Think of them as cellular proofreaders, constantly checking that genetic messages are accurate and functional. My research team first identified these proteins when they appeared as cellular partners that directly interact with viral proteins inside infected cells. This discovery intrigued us because UPF1 and DHX9 were unexpected candidates – they aren't typically associated with antiviral defence – yet they seemed perfectly positioned to detect or process viral RNA, likely because these proteins normally scan RNA for errors, making them well-suited to spot the unusual structures often found in viral genetic material. To test whether these proteins fight the virus, we used genetic techniques to silence the expression of UPF1 and DHX9 in tick cells, essentially removing these molecular guardians. We found that SFTSV viral growth increased significantly when these proteins were absent, demonstrating their antiviral function. This suggests that ticks may have evolved a different kind of immune defence known as non-canonical immunity. Instead of attacking viruses head-on using traditional immune systems, ticks seem to use more subtle strategies. In this case, their RNA quality-control proteins act as internal monitors. Because viral RNA often looks different from normal cellular RNA, these proteins may recognise it as unusual. Once detected, they can trigger internal control systems that slow down or block the virus from multiplying – helping the tick stay healthy without a full-blown immune response. Our research has important implications because UPF1 and DHX9 proteins exist in human cells too. Understanding how they work in ticks could reveal new ways to strengthen human antiviral defences or develop treatments that enhance these natural quality-control mechanisms. The research also opens possibilities for using these tolerance mechanisms to stop disease – either by strengthening similar defences in humans and animals, or by targeting them in ticks to break the chain of transmission. Future strategies might involve boosting antiviral proteins in wild tick populations or developing treatments that specifically target virus-tick interactions. Traditional approaches to disease control are struggling to keep up, especially as climate change helps ticks expand into new regions. To prevent future outbreaks, we need a deeper understanding of how ticks, and the viruses they carry, interact with both humans and animals. Learning how these tiny creatures tolerate deadly pathogens could be key to developing new tools that make people and animals less vulnerable to these diseases – or prevent ticks from passing them on in the first place. This article is republished from The Conversation under a Creative Commons license. Read the original article. Marine J. Petit receives funding from European Union's Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie grant agreement No 890970.
Medscape
13 hours ago
- Medscape
Specific Gut Bacteria Linked to Insomnia
Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators' assertion that the link is causal. Investigators identified 14 groups of bacteria associated with increased risk for insomnia and eight that were linked to a decreased risk. They also found that having insomnia was linked to reduced levels of seven groups of bacteria and an increase in the amounts of 12 others. 'The study revealed that a total of 41 gut bacterial taxa have causal associations with insomnia,' Shangyun Shi, first author and medical graduate student, Nanjing Medical University, Nanjing, China, told Medscape Medical News . 'While the impacts of particular bacterial groups on insomnia may vary, there are more important and less important species, which offer the road to potential intervention,' Shi added. Although the findings are intriguing, outside experts questioned whether the study actually demonstrated a causal relationship. The study was published online on August 12 in General Psychiatry . A Causal Relationship? Traditional studies have focused on associations between gut microbiota diversity or specific bacterial groups and insomnia but have struggled to establish if these relations are causal, Shi explained. To address this issue, investigators used Mendelian randomization analysis for the study, which can strengthen causal inference and identify specific causal bacterial groups. They conducted a two-sample Mendelian randomization analysis based on 386,533 participants in a previously published genome-wide insomnia study and gut microbiota data from 18,340 participants in the MiBioGen Alliance and 8208 individuals in the Dutch Microbiome Project. Results of the two-sample Mendelian randomization analysis of MiBioGen data suggested that 14 groups of bacteria may increase the risk for insomnia (odds ratio [OR], 1.01-1.04), whereas eight groups were likely to reduce the risks for this sleep disorder (OR, 0.97-0.99). ORs from the Dutch dataset were similar. However, after false discovery rate (FDR) correction, the causal association remained significant only for Clostridium innocuum (FDR, .007). Reverse Mendelian randomization analysis of the gut microbiota datasets was associated with up to a fourfold increase in the abundance of 12 groups of bacteria (OR, 1.65-4.43) and a 43%-79% decrease of seven taxa (OR, 0.21-0.57). Additional analyses also revealed significant bidirectional causal relationships between Odoribacter species and insomnia in the Dutch dataset. There was no evidence of pleiotropy. The use of Mendelian randomization analysis helped to avoid confounding factors and reverse causality, and multiple sensitivity analyses ensured the robustness of the results, the authors noted. However, investigators urged caution when generalizing the results to other populations, as study participants were of European descent and the microbiome varies between different ethnicities and geographies. Additionally, two-sample Mendelian randomization does not take into account the impact of environmental factors, such as diet and lifestyle, on insomnia. 'Our study offers preliminary evidence supporting a causal effect between insomnia and gut microbiota, providing valuable insights for the future development of microbiome-inspired treatment plans for insomnia,' the authors wrote. Experts Are Skeptical Reached for comment, Charlene Gamaldo, MD, sleep specialist and professor of neurology, Johns Hopkins Center for Sleep and Wellness, Columbia, Maryland, said the limitations cited by the authors give her pause. 'I have a difficult time understanding the authors' interpretation that these findings demonstrate bidirectional causality, or more specifically that gut biome flora causes insomnia,' Gamaldo told Medscape Medical News . 'I do think that the demonstration of an association between the two is interesting, especially since stress can cause gut biome change and stress is associated with insomnia,' she added. 'So, for me the question is whether these types of associations like stress, environmental triggers, etc, serve as upstream triggers to cause both insomnia and gut biome changes simultaneously or in succession?' John Saito, MD, a spokesperson for the American Academy of Sleep Medicine and a pulmonologist at Rady Children's Health, Orange, California, was also skeptical. 'This study offers preliminary evidence supporting a causal effect between insomnia and gut microbiota,' he told Medscape Medical News . 'More specifically, changes in the composition of the specific gut microbiota may increase insomnia risk.' However, the bidirectional causal relationship between specific gut microbiota and insomnia remain unclear, Saito added. While there is general recognition that disruption of gut microbiome may have central nervous system consequences, including alteration in sleep health, more research is needed before it would be feasible to diagnose or treat insomnia by focusing on changes in the gut microbiota, he said.
